HCA Healthcare Overview
HCA Healthcare Target Price
Analysts' 12-month price predictions for HCA.
Get informed when a big investor buys or sells
+ FollowShare Price
$410.5
Average Target Price
$491.20
19.7% upside
19.7% upside10 analysts in the last 4 months
High: $535 | Low: $413
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-04 | Truist Financial | $413 | 0.6% upside |  |
| 2026-06-04 | Bernstein | $413 | 0.6% upside | |
| 2026-04-27 | RBC Capital | $534 | 30.1% upside | |
| 2026-04-27 | KeyBanc | $510 | 24.2% upside | |
| 2026-04-27 | Oppenheimer | $520 | 26.7% upside | |
| 2026-04-27 | Wells Fargo | $436 | 6.2% upside | |
| 2026-04-27 | Truist Financial | $535 | 30.3% upside | |
| 2026-04-27 | Stephens | $530 | 29.1% upside | |
| 2026-04-27 | Barclays | $496 | 20.8% upside | |
| 2026-04-24 | Jefferies | $525 | 27.9% upside | |
| 2026-02-23 | UBS | $635 | 54.7% upside | |
| 2026-02-09 | Bernstein | $541 | 31.8% upside | |
| 2026-02-02 | Mizuho Securities | $540 | 31.5% upside | |
| 2026-01-30 | Wells Fargo | $481 | 17.2% upside | |
| 2026-01-28 | KeyBanc | $503 | 22.5% upside | |
| 2026-01-28 | RBC Capital | $555 | 35.2% upside | |
| 2026-01-28 | BarclaysAndrew Mok | $551 | 34.2% upside | |
| 2026-01-28 | UBS | $588 | 43.2% upside | |
| 2026-01-28 | Oppenheimer | $540 | 31.5% upside | |
| 2026-01-28 | UBS | $598 | 45.7% upside | |
| 2026-01-28 | KeyBanc | $550 | 34% upside | |
| 2026-01-22 | KeyBanc | $500 | 21.8% upside | |
| 2026-01-07 | Wells FargoStephen Baxter | $452 | 10.1% upside | |
| 2026-01-06 | Bernstein | $503 | 22.5% upside | |
| 2025-12-18 | Mizuho Securities | $520 | 26.7% upside | |
| 2025-10-27 | UBS | $525 | 27.9% upside | |
| 2025-10-27 | Barclays | $494 | 20.3% upside | |
| 2025-10-27 | RBC CapitalBen Hendrix | $482 | 17.4% upside | |
| 2025-10-27 | StephensRaj Kumar | $500 | 21.8% upside | |
| 2025-10-27 | Morgan Stanley | $425 | 3.5% upside | |
| 2025-10-27 | Goldman SachsScott Fidel | $520 | 26.7% upside | |
| 2025-10-27 | Bernstein | $417 | 1.6% upside | |
| 2025-10-27 | Truist Financial | $495 | 20.6% upside | |
| 2025-10-27 | Mizuho Securities | $505 | 23% upside | |
| 2025-10-27 | Oppenheimer | $500 | 21.8% upside | |
| 2025-10-27 | Raymond JamesSarah James | $525 | 27.9% upside | |
| 2025-10-17 | Mizuho Securities | $475 | 15.7% upside | |
| 2025-10-14 | UBS | $495 | 20.6% upside | |
| 2025-10-14 | Truist Financial | $460 | 12.1% upside | |
| 2025-10-14 | Goldman Sachs | $470 | 14.5% upside | |
| 2025-10-08 | UBS | $465 | 13.3% upside | |
| 2025-10-07 | Wells Fargo | $412 | 0.4% upside | |
| 2025-09-18 | Barclays | $445 | 8.4% upside | |
| 2025-07-28 | RBC CapitalBen Hendrix | $401 |  2.3% downside | |
| 2025-06-09 | Morgan StanleyCraig Hettenbach | $410 | 0.1% downside | |
| 2025-06-02 | BarclaysAndrew Mok | $416 | 1.3% upside | |
| 2025-01-07 | KeyBancMatthew Gillmor | $370 | 9.9% downside | |
| 2024-10-28 | Mizuho SecuritiesAnn Hynes | $425 | 3.5% upside | |
| 2024-10-28 | KeyBancMatthew Gillmor | $420 | 2.3% upside | |
| 2024-10-28 | OppenheimerMichael Wiederhorn | $400 | 2.6% downside | |